Gaedicke G - Search Results

1

Teaching vaccine safety communication to medical students and health professionals.

Rath B, Muhlhans S, Gaedicke G. Rath B, et al. Among authors: gaedicke g. Curr Drug Saf. 2015;10(1):23-6. doi: 10.2174/157488631001150407104537. Curr Drug Saf. 2015. PMID: 25859671

2

The importance of the patient voice in vaccination and vaccine safety-are we listening?

Holt D, Bouder F, Elemuwa C, Gaedicke G, Khamesipour A, Kisler B, Kochhar S, Kutalek R, Maurer W, Obermeier P, Seeber L, Trusko B, Gould S, Rath B. Holt D, et al. Among authors: gaedicke g. Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S146-S153. doi: 10.1016/j.cmi.2016.09.027. Epub 2016 Dec 6. Clin Microbiol Infect. 2016. PMID: 27939015 Free article.

3

A design thinking approach to effective vaccine safety communication.

Seeber L, Michl B, Rundblad G, Trusko B, Schnjakin M, Meinel C, Weinberg U, Gaedicke G, Rath B. Seeber L, et al. Among authors: gaedicke g. Curr Drug Saf. 2015;10(1):31-40. doi: 10.2174/157488631001150407105400. Curr Drug Saf. 2015. PMID: 25859673

4

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G. Feiterna-Sperling C, et al. Among authors: gaedicke g. Pediatr Infect Dis J. 2005 Dec;24(12):1083-8. doi: 10.1097/01.inf.0000183746.92218.f9. Pediatr Infect Dis J. 2005. PMID: 16371870 Clinical Trial.

5

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children.

Kanra G, Marchisio P, Feiterna-Sperling C, Gaedicke G, Lazar H, Durrer P, Kürsteiner O, Herzog C, Kara A, Principi N. Kanra G, et al. Among authors: gaedicke g. Pediatr Infect Dis J. 2004 Apr;23(4):300-6. doi: 10.1097/00006454-200404000-00005. Pediatr Infect Dis J. 2004. PMID: 15071282 Clinical Trial.

6

Pulmonary symptoms in Kawasaki disease.

Sengler C, Gaedicke G, Wahn U, Keitzer R. Sengler C, et al. Among authors: gaedicke g. Pediatr Infect Dis J. 2004 Aug;23(8):782-4. doi: 10.1097/01.inf.0000134313.86697.20. Pediatr Infect Dis J. 2004. PMID: 15295233

7

Kawasaki disease: update on diagnosis, treatment, and a still controversial etiology.

Fischer P, Uttenreuther-Fischer MM, Naoe S, Gaedicke G. Fischer P, et al. Among authors: gaedicke g. Pediatr Hematol Oncol. 1996 Nov-Dec;13(6):487-501. doi: 10.3109/08880019609030864. Pediatr Hematol Oncol. 1996. PMID: 8940732 Review.

8

Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Muehlhans S, von Kleist M, Gretchukha T, Terhardt M, Fegeler U, Maurer W, Namazova-Baranova L, Gaedicke G, Baranov A, Rath B. Muehlhans S, et al. Among authors: gaedicke g. Paediatr Drugs. 2014 Aug;16(4):321-30. doi: 10.1007/s40272-014-0075-3. Paediatr Drugs. 2014. PMID: 24849291

9

A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.

Huebener N, Fest S, Strandsby A, Michalsky E, Preissner R, Zeng Y, Gaedicke G, Lode HN. Huebener N, et al. Among authors: gaedicke g. Mol Cancer Ther. 2008 Jul;7(7):2241-51. doi: 10.1158/1535-7163.MCT-08-0109. Mol Cancer Ther. 2008. PMID: 18645033

10

Immature platelet count: a simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia.

Strauss G, Vollert C, von Stackelberg A, Weimann A, Gaedicke G, Schulze H. Strauss G, et al. Among authors: gaedicke g. Pediatr Blood Cancer. 2011 Oct;57(4):641-7. doi: 10.1002/pbc.22907. Epub 2010 Dec 22. Pediatr Blood Cancer. 2011. PMID: 21826780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results